Indel Therapeutics
Latest round
- Series B
Last raised
- Apr 2011
Total raised
- $1.4M
Investors
- 3
About Indel Therapeutics
Indel Therapeutics, founded in 2008 and headquartered in Vancouver, Canada, is dedicated to the development of groundbreaking therapies. The company has undergone strategic pivots to refine its focus on biotechnology solutions.Indel Therapeutics offers a suite of innovative therapies aimed at addressing specific medical challenges. Its core products include cutting-edge treatments designed to improve patient outcomes in the healthcare sector. The company focuses on developing solutions that enhance efficacy and safety, targeting a range of diseases.The company's revenue model is based on a combination of product sales and research partnerships, ensuring a steady cash flow while providing clients with access to its comprehensive therapeutic solutions. Engagements are typically structured as multi-year contracts, fostering long-term relationships and stability in revenue streams. The pricing model includes tiered plans to accommodate different healthcare providers, aligning with their operational needs and budgets.Indel Therapeutics aims to expand its product portfolio with new therapies set to launch by the end of 2024.
Who invested in Indel Therapeutics
3 investors across 1 round
See all investors in Indel Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Apr 28, 2011
Amount
$1.4M
Investors
Questions about Indel Therapeutics
Who invested in Indel Therapeutics?
Indel Therapeutics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Indel Therapeutics raised?
Indel Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Indel Therapeutics last raise money?
Indel Therapeutics's most recent round on record is a Series B, in Apr 2011.
What does Indel Therapeutics do?
Indel Therapeutics, founded in 2008 and headquartered in Vancouver, Canada, is dedicated to the development of groundbreaking therapies.
Where is Indel Therapeutics headquartered?
Indel Therapeutics is headquartered in Vancouver, Canada.
Which VCs invest in companies like Indel Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Indel Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Indel Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.